Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Vorinostat potentiates cisplatin-5-fluorouracil combination by inhibiting chemotherapy-induced EGFR nuclear translocation and increasing cisplatin uptake.

Piro G, Roca MS, Bruzzese F, Carbone C, Iannelli F, Leone A, Volpe MG, Budillon A, Di Gennaro E.

Mol Cancer Ther. 2019 Jun 12. pii: molcanther.1117.2018. doi: 10.1158/1535-7163.MCT-18-1117. [Epub ahead of print]

PMID:
31189612
2.

A novel mutation in KCNQ3-related benign familial neonatal epilepsy: electroclinical features and neurodevelopmental outcome.

Piro E, Nardello R, Gennaro E, Fontana A, Taglialatela M, Donato Mangano G, Corsello G, Mangano S.

Epileptic Disord. 2019 Feb 1;21(1):87-91. doi: 10.1684/epd.2019.1030.

PMID:
30782577
3.

Chewing induced reflex seizures ("eating epilepsy") and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases.

von Stülpnagel C, Hartlieb T, Borggräfe I, Coppola A, Gennaro E, Eschermann K, Kiwull L, Kluger F, Krois I, Møller RS, Rössler F, Santulli L, Schwermer C, Wallacher-Scholz B, Zara F, Wolf P, Kluger G.

Seizure. 2019 Feb;65:131-137. doi: 10.1016/j.seizure.2018.12.020. Epub 2018 Dec 22. Review.

PMID:
30685520
4.

FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the FMR1 Gene.

Fernández E, Gennaro E, Pirozzi F, Baldo C, Forzano F, Turolla L, Faravelli F, Gastaldo D, Coviello D, Grasso M, Bagni C.

Front Genet. 2018 Nov 2;9:442. doi: 10.3389/fgene.2018.00442. eCollection 2018.

5.

Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.

Dilena R, DiFrancesco JC, Soldovieri MV, Giacobbe A, Ambrosino P, Mosca I, Galli MA, Guez S, Fumagalli M, Miceli F, Cattaneo D, Darra F, Gennaro E, Zara F, Striano P, Castellotti B, Gellera C, Varesio C, Veggiotti P, Taglialatela M.

Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.

PMID:
30112700
6.

A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges.

Lanuti P, Simeone P, Rotta G, Almici C, Avvisati G, Azzaro R, Bologna G, Budillon A, Di Cerbo M, Di Gennaro E, Di Martino ML, Diodato A, Doretto P, Ercolino E, Falda A, Gregorj C, Leone A, Losa F, Malara N, Marini M, Mastroroberto P, Mollace V, Morelli M, Muggianu E, Musolino G, Neva A, Pierdomenico L, Pinna S, Piovani G, Roca MS, Russo D, Scotti L, Tirindelli MC, Trunzo V, Venturella R, Vitagliano C, Zullo F, Marchisio M, Miscia S.

Sci Rep. 2018 Apr 11;8(1):5823. doi: 10.1038/s41598-018-24234-0.

7.

Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.

Terranova-Barberio M, Pecori B, Roca MS, Imbimbo S, Bruzzese F, Leone A, Muto P, Delrio P, Avallone A, Budillon A, Di Gennaro E.

J Exp Clin Cancer Res. 2017 Dec 6;36(1):177. doi: 10.1186/s13046-017-0647-5.

8.

CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation.

Bernardo P, Galletta D, Iasevoli F, D'Ambrosio L, Troisi S, Gennaro E, Zara F, Striano S, de Bartolomeis A, Coppola A.

Seizure. 2017 Oct;51:186-189. doi: 10.1016/j.seizure.2017.09.001. Epub 2017 Sep 6. No abstract available.

9.

mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy.

Bartolomeo R, Cinque L, De Leonibus C, Forrester A, Salzano AC, Monfregola J, De Gennaro E, Nusco E, Azario I, Lanzara C, Serafini M, Levine B, Ballabio A, Settembre C.

J Clin Invest. 2017 Oct 2;127(10):3717-3729. doi: 10.1172/JCI94130. Epub 2017 Sep 5.

10.

Role of Oxygen Deposition Pressure in the Formation of Ti Defect States in TiO2(001) Anatase Thin Films.

Gobaut B, Orgiani P, Sambri A, di Gennaro E, Aruta C, Borgatti F, Lollobrigida V, Céolin D, Rueff JP, Ciancio R, Bigi C, Das PK, Fujii J, Krizmancic D, Torelli P, Vobornik I, Rossi G, Miletto Granozio F, Scotti di Uccio U, Panaccione G.

ACS Appl Mater Interfaces. 2017 Jul 12;9(27):23099-23106. doi: 10.1021/acsami.7b03181. Epub 2017 Jun 26.

11.

SNORD116 deletions cause Prader-Willi syndrome with a mild phenotype and macrocephaly.

Fontana P, Grasso M, Acquaviva F, Gennaro E, Galli ML, Falco M, Scarano F, Scarano G, Lonardo F.

Clin Genet. 2017 Oct;92(4):440-443. doi: 10.1111/cge.13005. Epub 2017 Mar 30.

PMID:
28266014
12.

A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.

Assenza G, Benvenga A, Gennaro E, Tombini M, Campana C, Assenza F, Di Pino G, Di Lazzaro V.

Epilepsia. 2017 Feb;58(2):e31-e35. doi: 10.1111/epi.13626. Epub 2016 Nov 26. Review.

13.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.

Caponigro F, Di Gennaro E, Ionna F, Longo F, Aversa C, Pavone E, Maglione MG, Di Marzo M, Muto P, Cavalcanti E, Petrillo A, Sandomenico F, Maiolino P, D'Aniello R, Botti G, De Cecio R, Losito NS, Scala S, Trotta A, Zotti AI, Bruzzese F, Daponte A, Calogero E, Montano M, Pontone M, De Feo G, Perri F, Budillon A.

BMC Cancer. 2016 Nov 25;16(1):918.

14.

Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy.

Dilena R, Striano P, Gennaro E, Bassi L, Olivotto S, Tadini L, Mosca F, Barbieri S, Zara F, Fumagalli M.

Brain Dev. 2017 Apr;39(4):345-348. doi: 10.1016/j.braindev.2016.10.015. Epub 2016 Nov 19.

PMID:
27876397
15.

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

Carbone C, Di Gennaro E, Piro G, Milone MR, Pucci B, Caraglia M, Budillon A.

Amino Acids. 2017 Mar;49(3):517-528. doi: 10.1007/s00726-016-2338-5. Epub 2016 Oct 19.

PMID:
27761756
16.

Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents.

Zotti AI, Di Gennaro E, Corvino A, Frecentese F, Magli E, Perissutti E, Cirino G, Roviezzo F, Terranova-Barberio M, Iannelli F, Caliendo G, Santagada V, Fiorino F, Budillon A, Severino B.

Anticancer Agents Med Chem. 2017;17(7):973-981. doi: 10.2174/1871520616666160926120904.

PMID:
27671294
17.

Pitfalls in genetic testing: the story of missed SCN1A mutations.

Djémié T, Weckhuysen S, von Spiczak S, Carvill GL, Jaehn J, Anttonen AK, Brilstra E, Caglayan HS, de Kovel CG, Depienne C, Gaily E, Gennaro E, Giraldez BG, Gormley P, Guerrero-López R, Guerrini R, Hämäläinen E, Hartmann C, Hernandez-Hernandez L, Hjalgrim H, Koeleman BP, Leguern E, Lehesjoki AE, Lemke JR, Leu C, Marini C, McMahon JM, Mei D, Møller RS, Muhle H, Myers CT, Nava C, Serratosa JM, Sisodiya SM, Stephani U, Striano P, van Kempen MJ, Verbeek NE, Usluer S, Zara F, Palotie A, Mefford HC, Scheffer IE, De Jonghe P, Helbig I, Suls A; EuroEPINOMICS‐RES Dravet working group.

Mol Genet Genomic Med. 2016 Apr 14;4(4):457-64. doi: 10.1002/mgg3.217. eCollection 2016 Jul.

18.

The crucial role of FBXO28 in the pathogenesis of the 1q41q42 microdeletion syndrome.

Papetti L, Schettini L, Garone G, Gennaro E, Malacarne M, Properzi E, Spalice A.

Am J Med Genet A. 2016 Nov;170(11):3041-3042. doi: 10.1002/ajmg.a.37753. Epub 2016 May 17. No abstract available.

PMID:
27184008
19.

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.

Ciardiello C, Roca MS, Noto A, Bruzzese F, Moccia T, Vitagliano C, Di Gennaro E, Ciliberto G, Roscilli G, Aurisicchio L, Marra E, Mancini R, Budillon A, Leone A.

Oncotarget. 2016 Apr 12;7(15):19559-74. doi: 10.18632/oncotarget.7195.

20.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A.

BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y.

21.

Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.

Terranova-Barberio M, Roca MS, Zotti AI, Leone A, Bruzzese F, Vitagliano C, Scogliamiglio G, Russo D, D'Angelo G, Franco R, Budillon A, Di Gennaro E.

Oncotarget. 2016 Feb 16;7(7):7715-31. doi: 10.18632/oncotarget.6802.

22.

Tunable spin polarization and superconductivity in engineered oxide interfaces.

Stornaiuolo D, Cantoni C, De Luca GM, Di Capua R, Di Gennaro E, Ghiringhelli G, Jouault B, Marrè D, Massarotti D, Miletto Granozio F, Pallecchi I, Piamonteze C, Rusponi S, Tafuri F, Salluzzo M.

Nat Mater. 2016 Mar;15(3):278-83. doi: 10.1038/nmat4491. Epub 2015 Dec 7.

PMID:
26641020
23.

Universal electronic structure of polar oxide hetero-interfaces.

Treske U, Heming N, Knupfer M, Büchner B, Di Gennaro E, Khare A, Di Uccio US, Granozio FM, Krause S, Koitzsch A.

Sci Rep. 2015 Sep 28;5:14506. doi: 10.1038/srep14506.

24.

Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.

Leone A, Roca MS, Ciardiello C, Terranova-Barberio M, Vitagliano C, Ciliberto G, Mancini R, Di Gennaro E, Bruzzese F, Budillon A.

Free Radic Biol Med. 2015 Dec;89:287-99. doi: 10.1016/j.freeradbiomed.2015.07.155. Epub 2015 Sep 26.

PMID:
26409771
25.

Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.

Lanuti P, Rotta G, Almici C, Avvisati G, Budillon A, Doretto P, Malara N, Marini M, Neva A, Simeone P, Di Gennaro E, Leone A, Falda A, Tozzoli R, Gregorj C, Di Cerbo M, Trunzo V, Mollace V, Marchisio M, Miscia S.

Cytometry A. 2016 Mar;89(3):259-70. doi: 10.1002/cyto.a.22730. Epub 2015 Aug 25.

26.

Maternal germinal mosaicism for SCN1A in sibs with a mild form of Dravet syndrome.

Guala A, Peruzzi C, Gennaro E, Pennese L, Danesino C.

Am J Med Genet A. 2015 May;167A(5):1165-7. doi: 10.1002/ajmg.a.36990. No abstract available.

PMID:
25885068
27.

Photoresponse dynamics in amorphous-LaAlO3/SrTiO3 interfaces.

Di Gennaro E, Coscia U, Ambrosone G, Khare A, Granozio FM, di Uccio US.

Sci Rep. 2015 Feb 11;5:8393. doi: 10.1038/srep08393.

28.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Terranova Barberio M, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A.

BMC Cancer. 2014 Nov 24;14:875. doi: 10.1186/1471-2407-14-875.

29.

Mild Lafora disease: clinical, neurophysiologic, and genetic findings.

Ferlazzo E, Canafoglia L, Michelucci R, Gambardella A, Gennaro E, Pasini E, Riguzzi P, Plasmati R, Volpi L, Labate A, Gasparini S, Villani F, Casazza M, Viri M, Zara F, Minassian BA, Turnbull J, Serratosa JM, Guerrero-López R, Franceschetti S, Aguglia U.

Epilepsia. 2014 Dec;55(12):e129-33. doi: 10.1111/epi.12806. Epub 2014 Sep 30.

30.

The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.

Andreotti M, Pirillo MF, Liotta G, Jere H, Maulidi M, Sagno JB, Luhanga R, Amici R, Mancini MG, Gennaro E, Marazzi MC, Vella S, Giuliano M, Palombi L, Mancinelli S.

BMC Infect Dis. 2014 Apr 4;14:180. doi: 10.1186/1471-2334-14-180.

31.

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.

Di Marzo D, Forte IM, Indovina P, Di Gennaro E, Rizzo V, Giorgi F, Mattioli E, Iannuzzi CA, Budillon A, Giordano A, Pentimalli F.

Cell Cycle. 2014;13(4):652-65. doi: 10.4161/cc.27546. Epub 2013 Dec 17.

PMID:
24345738
32.

A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis.

Grasso M, Boon EM, Filipovic-Sadic S, van Bunderen PA, Gennaro E, Cao R, Latham GJ, Hadd AG, Coviello DA.

J Mol Diagn. 2014 Jan;16(1):23-31. doi: 10.1016/j.jmoldx.2013.09.004. Epub 2013 Oct 29.

33.

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.

Bruzzese F, Pucci B, Milone MR, Ciardiello C, Franco R, Chianese MI, Rocco M, Di Gennaro E, Leone A, Luciano A, Arra C, Santini D, Caraglia M, Budillon A.

Cell Death Dis. 2013 Oct 24;4:e878. doi: 10.1038/cddis.2013.406.

34.

New perspective for an old antidiabetic drug: metformin as anticancer agent.

Leone A, Di Gennaro E, Bruzzese F, Avallone A, Budillon A.

Cancer Treat Res. 2014;159:355-76. doi: 10.1007/978-3-642-38007-5_21. Review.

PMID:
24114491
35.

Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.

Avallone A, Di Gennaro E, Silvestro L, Iaffaioli VR, Budillon A.

Expert Opin Drug Saf. 2014 Jan;13(1):113-29. doi: 10.1517/14740338.2014.845167. Epub 2013 Oct 5. Review.

PMID:
24093908
36.

The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations.

Ricci MT, Pennese L, Gismondi V, Perfumo C, Grasso M, Gennaro E, Bruzzi P, Varesco L.

Eur J Hum Genet. 2014 Feb;22(2):280-2. doi: 10.1038/ejhg.2013.193. Epub 2013 Sep 25.

37.

Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.

Liotta G, Mancinelli S, Nielsen-Saines K, Gennaro E, Scarcella P, Magid NA, Germano P, Jere H, Guidotti G, Buonomo E, Ciccacci F, Palombi L, Marazzi MC.

PLoS One. 2013 Aug 19;8(8):e71653. doi: 10.1371/journal.pone.0071653. eCollection 2013. Erratum in: PLoS One. 2013;8(8). doi: 10.1371/annotation/9ab4708e-650e-411a-b72f-bb85e0845469. Gennaro, E [corrected to Gennaro, Elisabetta]; Guidotti, Gianni [corrected to Guidotti, Giovanni].

38.

MS-MLPA analysis for FMR1 gene: evaluation in a routine diagnostic setting.

Gatta V, Gennaro E, Franchi S, Cecconi M, Antonucci I, Tommasi M, Palka G, Coviello D, Stuppia L, Grasso M.

BMC Med Genet. 2013 Aug 5;14:79. doi: 10.1186/1471-2350-14-79.

39.

Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.

Marazzi MC, De Luca S, Palombi L, Scarcella P, Ciccacci F, Ceffa S, Nielsen-Saines K, De Luca A, Mancinelli S, Gennaro E, Zimba I, Liotta G, Buonomo E.

Pediatr Infect Dis J. 2014 Mar;33(3):295-300. doi: 10.1097/INF.0b013e3182a0994b.

PMID:
23799517
40.

Improving the quality of life of terminally ill oncological patients: the example of palliative care at Hospice Villa Speranza.

Turriziani A, Attanasio G, Cogliandolo S, Scarcella F, Sangalli L, De Gennaro E, Scopa A, Genualdo A, Nazzicone G, Ricciotti MA, Cassano A.

Future Oncol. 2013 Jun;9(6):771-6. doi: 10.2217/fon.13.59. No abstract available. Erratum in: Future Oncol. 2013 Aug;9(8):1240. Scarcella, Francesco [added];Ricciotti, Mariadelaide [corrected to Ricciotti, Maria Adelaide].

41.

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

Milone MR, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M, Budillon A.

Cell Death Dis. 2013 May 23;4:e641. doi: 10.1038/cddis.2013.165. Erratum in: Cell Death Dis. 2014;5:e1276.

42.

Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.

Zara F, Specchio N, Striano P, Robbiano A, Gennaro E, Paravidino R, Vanni N, Beccaria F, Capovilla G, Bianchi A, Caffi L, Cardilli V, Darra F, Bernardina BD, Fusco L, Gaggero R, Giordano L, Guerrini R, Incorpora G, Mastrangelo M, Spaccini L, Laverda AM, Vecchi M, Vanadia F, Veggiotti P, Viri M, Occhi G, Budetta M, Taglialatela M, Coviello DA, Vigevano F, Minetti C.

Epilepsia. 2013 Mar;54(3):425-36. doi: 10.1111/epi.12089. Epub 2013 Jan 29.

43.

Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.

Canafoglia L, Gennaro E, Capovilla G, Gobbi G, Boni A, Beccaria F, Viri M, Michelucci R, Agazzi P, Assereto S, Coviello DA, Di Stefano M, Rossi Sebastiano D, Franceschetti S, Zara F.

Epilepsia. 2012 Dec;53(12):2120-7. doi: 10.1111/j.1528-1167.2012.03718.x. Erratum in: Epilepsia. 2013 Jul;54(7):1333.

44.

Control of the light transmission through a quasiperiodic waveguide.

T PR, Zito G, Di Gennaro E, Abbate G, Andreone A.

Opt Express. 2012 Nov 5;20(23):26056-61. doi: 10.1364/OE.20.026056.

PMID:
23187421
45.

A systematic review of the literature concerning the relationship between obesity and mortality in the elderly.

Donini LM, Savina C, Gennaro E, De Felice MR, Rosano A, Pandolfo MM, Del Balzo V, Cannella C, Ritz P, Chumlea WC.

J Nutr Health Aging. 2012 Jan;16(1):89-98. Review.

46.

Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.

Masuelli L, Budillon A, Marzocchella L, Mrozek MA, Vitolo D, Di Gennaro E, Losito S, Sale P, Longo F, Ionna F, Lista F, Muraro R, Modesti A, Bei R.

J Cell Physiol. 2012 Sep;227(9):3344-53. doi: 10.1002/jcp.24034.

PMID:
22213373
47.

Tissue transglutaminase: a new target to reverse cancer drug resistance.

Budillon A, Carbone C, Di Gennaro E.

Amino Acids. 2013 Jan;44(1):63-72. doi: 10.1007/s00726-011-1167-9. Epub 2011 Dec 1. Review.

48.

Fever as a seizure precipitant factor in Panayiotopoulos syndrome: a clinical and genetic study.

Cordelli DM, Aldrovandi A, Gentile V, Garone C, Conti S, Aceti A, Gennaro E, Zara F, Franzoni E.

Seizure. 2012 Mar;21(2):141-3. doi: 10.1016/j.seizure.2011.09.013. Epub 2011 Oct 19.

49.

The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies.

Nicita F, De Liso P, Danti FR, Papetti L, Ursitti F, Castronovo A, Allemand F, Gennaro E, Zara F, Striano P, Spalice A.

Seizure. 2012 Jan;21(1):3-11. doi: 10.1016/j.seizure.2011.08.007. Epub 2011 Sep 13. Review.

50.

Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.

Bianchi L, Bruzzese F, Leone A, Gagliardi A, Puglia M, Di Gennaro E, Rocco M, Gimigliano A, Pucci B, Armini A, Bini L, Budillon A.

Proteomics. 2011 Sep;11(18):3725-42. doi: 10.1002/pmic.201100092.

PMID:
21761561

Supplemental Content

Loading ...
Support Center